IP Patent News
 

PSA test is still the best option for diagnosing prostate cancer

March 12, 2010
[Story ID: 810]

When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay

tags: , , ,
posted in Uncategorized by admin

Follow comments via the RSS Feed | Leave a comment | Trackback URL

Leave Your Comment

You must be logged in to post a comment.

 
ABOUT | CONTACT | ip-patent-news.com 2007 - 2010